ABN Amro Investment Solutions Buys New Shares in MetLife, Inc. $MET

ABN Amro Investment Solutions purchased a new stake in shares of MetLife, Inc. (NYSE:MET) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 175,150 shares of the financial services provider’s stock, valued at approximately $14,086,000.

Several other institutional investors and hedge funds also recently modified their holdings of MET. Price T Rowe Associates Inc. MD lifted its stake in shares of MetLife by 7.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider’s stock worth $2,126,734,000 after acquiring an additional 1,824,907 shares in the last quarter. Pzena Investment Management LLC increased its holdings in shares of MetLife by 6.8% in the 2nd quarter. Pzena Investment Management LLC now owns 9,144,635 shares of the financial services provider’s stock worth $735,412,000 after acquiring an additional 585,671 shares during the period. Ameriprise Financial Inc. raised its stake in MetLife by 3.6% during the 1st quarter. Ameriprise Financial Inc. now owns 7,406,512 shares of the financial services provider’s stock valued at $594,410,000 after acquiring an additional 259,993 shares in the last quarter. Northern Trust Corp raised its position in shares of MetLife by 0.8% during the 1st quarter. Northern Trust Corp now owns 7,109,423 shares of the financial services provider’s stock worth $570,816,000 after buying an additional 57,221 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of MetLife by 3.7% in the first quarter. Dimensional Fund Advisors LP now owns 6,671,435 shares of the financial services provider’s stock valued at $535,568,000 after buying an additional 236,698 shares during the period. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of MetLife stock opened at $80.17 on Thursday. The stock’s fifty day simple moving average is $79.89 and its 200 day simple moving average is $78.90. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $52.82 billion, a PE ratio of 13.59, a PEG ratio of 0.70 and a beta of 0.87.

MetLife (NYSE:MET) last released its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, beating the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The firm had revenue of $12.46 billion for the quarter, compared to analysts’ expectations of $18.64 billion. During the same quarter in the previous year, the business posted $1.95 EPS. The business’s quarterly revenue was down 5.9% compared to the same quarter last year. On average, research analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be given a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, November 4th. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. MetLife’s dividend payout ratio is presently 42.75%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. Wolfe Research raised MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Piper Sandler cut MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 target price for the company. in a research report on Friday, September 19th. UBS Group cut their target price on shares of MetLife from $96.00 to $95.00 and set a “buy” rating for the company in a research note on Thursday, November 6th. Wells Fargo & Company lowered their price target on shares of MetLife from $96.00 to $92.00 and set an “overweight” rating on the stock in a report on Friday, November 7th. Finally, Barclays lifted their price target on shares of MetLife from $93.00 to $98.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $95.00.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.